Search - tctmd.com

Displaying 401 - 420 of 849

Sort: Relevancy | Date

News Daily News

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

L.A. McKeown

October 04, 2013

News Daily News

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Jason Kahn

October 04, 2013

Presentation

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Presenter: M. Kenaan

October 02, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Jason Kahn

September 27, 2013

News Daily News

Marriage Linked to Better PCI Outcomes

Yael L. Maxwell

September 27, 2013

News Daily News

Matrimonio relacionado con mejores resultados de la PCI

Yael L. Maxwell

September 27, 2013

News Daily News

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

Jason Kahn

September 27, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

News Daily News

Registros del NCDR Dan una Valoración Nacional sobre Atención Cardiovascular

September 20, 2013

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Advertisement

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

Triple Antiplatelet Therapy May be Better for Longer Stent Lengths

Marriage Linked to Better PCI Outcomes

Matrimonio relacionado con mejores resultados de la PCI

La Terapia Antiplaquetaria Triple podría ser Mejor para Longitudes de Stent Más Largas

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Registros del NCDR Dan una Valoración Nacional sobre Atención Cardiovascular

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content